Accessibility Menu
 
Precigen logo

Precigen

(NASDAQ) PGEN

Current Price$3.88
Market Cap$1.38B
Since IPO (2013)-87%
5 Year-48%
1 Year+142%
1 Month-2%

Precigen Financials at a Glance

Market Cap

$1.38B

Revenue (TTM)

$9.68M

Net Income (TTM)

$250.64M

EPS (TTM)

$-1.40

P/E Ratio

-2.78

Dividend

$0.00

Beta (Volatility)

1.78 (High)

Price

$3.88

Volume

881,361

Open

$4.04

Previous Close

$3.88

Daily Range

$3.75 - $4.26

52-Week Range

$1.11 - $5.46

PGEN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Precigen

Industry

Biotechnology

Employees

160

CEO

Helen Sabzevari, PhD

Headquarters

Germantown, MD 20876, US

PGEN Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

-11%

Net Income Margin

-26%

Return on Equity

-572%

Return on Capital

-89%

Return on Assets

-2%

Earnings Yield

-35.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.38B

Shares Outstanding

353.82M

Volume

881.36K

Short Interest

0.00%

Avg. Volume

4.40M

Financials (TTM)

Gross Profit

$3.59M

Operating Income

$106.60M

EBITDA

$106.60M

Operating Cash Flow

$87.83M

Capital Expenditure

$2.00M

Free Cash Flow

$87.83M

Cash & ST Invst.

$97.86M

Total Debt

$5.12M

Precigen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$4.57M

+283.6%

Gross Profit

$2.16M

+10181.0%

Gross Margin

47.29%

N/A

Market Cap

$1.38B

N/A

Market Cap/Employee

$9.63M

N/A

Employees

143

N/A

Net Income

$23.50M

-19.1%

EBITDA

$21.67M

-13.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$92.74M

+0.4%

Accounts Receivable

$4.36M

+275.1%

Inventory

$9.58M

N/A

Long Term Debt

$3.98M

-12.5%

Short Term Debt

$1.14M

+18.8%

Return on Assets

-1.60%

N/A

Return on Invested Capital

-89.34%

N/A

Free Cash Flow

$24.08M

-159.8%

Operating Cash Flow

$23.46M

-184.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NKTRNektar Therapeutics
$70.97-1.54%
IMTXImmatics N.V.
$9.77+0.31%
ORICORIC Pharmaceuticals, Inc.
$12.38+5.81%
TRMLTourmaline Bio, Inc.
$47.98+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$8.28-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.25-0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
IBITiShares Bitcoin Trust
$38.82-0.03%

Questions About PGEN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.